Irinotecan and Capecitabine in Treating Patients With Solid Tumors

NCT00003867 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Cancer

Interventions

DRUG: capecitabine
DRUG: irinotecan hydrochloride

Sponsor

Montefiore Medical Center

Collaborators

[object Object]